skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 25,442  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Evaluation of a SARS-CoV-2 Surrogate Virus Neutralization Test for Detection of Antibody in Human, Canine, Cat, and Hamster Sera
Material Type:
Article
Add to My Research

Evaluation of a SARS-CoV-2 Surrogate Virus Neutralization Test for Detection of Antibody in Human, Canine, Cat, and Hamster Sera

Journal of clinical microbiology, 2021-01, Vol.59 (2) [Peer Reviewed Journal]

Copyright © 2021 American Society for Microbiology. ;Copyright © 2021 American Society for Microbiology. 2021 American Society for Microbiology ;ISSN: 0095-1137 ;EISSN: 1098-660X ;DOI: 10.1128/JCM.02504-20 ;PMID: 33139421

Full text available

2
Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays
Material Type:
Article
Add to My Research

Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays

Viruses, 2020-05, Vol.12 (5), p.513 [Peer Reviewed Journal]

COPYRIGHT 2020 MDPI AG ;Attribution ;2020 by the authors. 2020 ;ISSN: 1999-4915 ;EISSN: 1999-4915 ;DOI: 10.3390/v12050513 ;PMID: 32384820

Full text available

3
Development of a Rapid Focus Reduction Neutralization Test Assay for Measuring SARS‐CoV‐2 Neutralizing Antibodies
Material Type:
Article
Add to My Research

Development of a Rapid Focus Reduction Neutralization Test Assay for Measuring SARS‐CoV‐2 Neutralizing Antibodies

Current Protocols in Immunology, 2020-12, Vol.131 (1)

2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://novel-coronavirus.onlinelibrary.wiley.com ;DOI: 10.1002/cpim.116

Digital Resources/Online E-Resources

4
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera
Material Type:
Article
Add to My Research

Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera

Nature medicine, 2021-04, Vol.27 (4), p.620-621 [Peer Reviewed Journal]

COPYRIGHT 2021 Nature Publishing Group ;The Author(s), under exclusive licence to Springer Nature America, Inc. part of Springer Nature 2021. ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-021-01270-4 ;PMID: 33558724

Full text available

5
Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization
Material Type:
Article
Add to My Research

Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization

Cell host & microbe, 2021-05, Vol.29 (5), p.747-751.e4 [Peer Reviewed Journal]

2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021 Elsevier Inc. 2021 Elsevier Inc. ;ISSN: 1931-3128 ;EISSN: 1934-6069 ;DOI: 10.1016/j.chom.2021.04.007 ;PMID: 33887205

Full text available

6
Antibody-mediated neutralization of SARS-CoV-2
Material Type:
Article
Add to My Research

Antibody-mediated neutralization of SARS-CoV-2

Immunity, 2022-06, Vol.55 (6), p.925-944 [Peer Reviewed Journal]

2022 Elsevier Inc. ;Copyright © 2022 Elsevier Inc. All rights reserved. ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2022 Elsevier Inc. 2022 Elsevier Inc. ;ISSN: 1074-7613 ;EISSN: 1097-4180 ;DOI: 10.1016/j.immuni.2022.05.005 ;PMID: 35623355

Digital Resources/Online E-Resources

7
Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
Material Type:
Article
Add to My Research

Considerable escape of SARS-CoV-2 Omicron to antibody neutralization

Nature (London), 2022-02, Vol.602 (7898), p.671-675 [Peer Reviewed Journal]

2021. The Author(s), under exclusive licence to Springer Nature Limited. ;Copyright Nature Publishing Group Feb 24, 2022 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-04389-z ;PMID: 35016199

Full text available

8
Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2
Material Type:
Article
Add to My Research

Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2

Nature (London), 2022-02, Vol.602 (7898), p.676-681 [Peer Reviewed Journal]

2021. The Author(s), under exclusive licence to Springer Nature Limited. ;Copyright Nature Publishing Group Feb 24, 2022 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-04388-0 ;PMID: 35016198

Full text available

9
Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
Material Type:
Article
Add to My Research

Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization

Nature (London), 2022-02, Vol.602 (7898), p.654-656 [Peer Reviewed Journal]

2021. The Author(s). ;Copyright Nature Publishing Group Feb 24, 2022 ;The Author(s) 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-04387-1 ;PMID: 35016196

Full text available

10
Highly active engineered IgG3 antibodies against SARS-CoV-2
Material Type:
Article
Add to My Research

Highly active engineered IgG3 antibodies against SARS-CoV-2

Proceedings of the National Academy of Sciences - PNAS, 2021-10, Vol.118 (42), p.1 [Peer Reviewed Journal]

Copyright © 2021 the Author(s). Published by PNAS. ;Copyright National Academy of Sciences Oct 19, 2021 ;Copyright © 2021 the Author(s). Published by PNAS. 2021 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.2107249118 ;PMID: 34599091

Full text available

11
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
Material Type:
Article
Add to My Research

Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera

Cell, 2021-04, Vol.184 (9), p.2348-2361.e6 [Peer Reviewed Journal]

2021 The Author(s) ;Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved. ;2021 The Author(s) 2021 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2021.02.037 ;PMID: 33730597

Full text available

12
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
Material Type:
Article
Add to My Research

Robust neutralizing antibodies to SARS-CoV-2 infection persist for months

Science, 2020-12, Vol.370 (6521) [Peer Reviewed Journal]

2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abd7728

Digital Resources/Online E-Resources

13
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies
Material Type:
Article
Add to My Research

SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies

Cell, 2021-04, Vol.184 (9), p.2384-2393.e12 [Peer Reviewed Journal]

2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021 Elsevier Inc. 2021 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2021.03.036 ;PMID: 33794143

Full text available

14
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
Material Type:
Article
Add to My Research

Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies

Nature medicine, 2021-04, Vol.27 (4), p.717-726 [Peer Reviewed Journal]

COPYRIGHT 2021 Nature Publishing Group ;The Author(s), under exclusive licence to Springer Nature America, Inc. part of Springer Nature 2021. ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-021-01294-w ;PMID: 33664494

Full text available

15
Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
Material Type:
Article
Add to My Research

Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies

Science, 2020-08, Vol.369 (6506) [Peer Reviewed Journal]

2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abd0831

Digital Resources/Online E-Resources

16
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum
Material Type:
Article
Add to My Research

Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum

Cell, 2021-08, Vol.184 (16), p.4220-4236.e13 [Peer Reviewed Journal]

2021 The Authors ;Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved. ;2021 The Authors 2021 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2021.06.020 ;PMID: 34242578

Full text available

17
Evaluation of High-Throughput SARS-CoV-2 Serological Assays in a Longitudinal Cohort of Patients with Mild COVID-19: Clinical Sensitivity, Specificity, and Association with Virus Neutralization Test
Material Type:
Article
Add to My Research

Evaluation of High-Throughput SARS-CoV-2 Serological Assays in a Longitudinal Cohort of Patients with Mild COVID-19: Clinical Sensitivity, Specificity, and Association with Virus Neutralization Test

Clinical chemistry (Baltimore, Md.), 2021-05, Vol.67 (5), p.742-752 [Peer Reviewed Journal]

American Association for Clinical Chemistry 2021. All rights reserved. For permissions, please email: journals.permissions@oup.com. 2021 ;American Association for Clinical Chemistry 2021. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;COPYRIGHT 2021 Oxford University Press ;Distributed under a Creative Commons Attribution 4.0 International License ;2021 American Association for Clinical Chemistry 2021 ;ISSN: 0009-9147 ;EISSN: 1530-8561 ;DOI: 10.1093/clinchem/hvaa336 ;PMID: 33399823

Full text available

18
Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
Material Type:
Article
Add to My Research

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies

Nature (London), 2022-02, Vol.602 (7898), p.657-663 [Peer Reviewed Journal]

2021. The Author(s). ;Copyright Nature Publishing Group Feb 24, 2022 ;The Author(s) 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-04385-3 ;PMID: 35016194

Full text available

19
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7
Material Type:
Article
Add to My Research

Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7

Nature (London), 2021-05, Vol.593 (7857), p.130-135 [Peer Reviewed Journal]

Copyright Nature Publishing Group May 6, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03398-2 ;PMID: 33684923

Full text available

20
Spike mutation D614G alters SARS-CoV-2 fitness
Material Type:
Article
Add to My Research

Spike mutation D614G alters SARS-CoV-2 fitness

Nature (London), 2021-04, Vol.592 (7852), p.116-121 [Peer Reviewed Journal]

Copyright Nature Publishing Group Apr 1, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-020-2895-3 ;PMID: 33106671

Full text available

Results 1 - 20 of 25,442  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (22,734)

Refine My Results

Creation Date 

From To
  1. Before 1961  (116)
  2. 1961 To 1975  (3,355)
  3. 1976 To 1990  (3,598)
  4. 1991 To 2006  (6,910)
  5. After 2006  (11,494)
  6. More options open sub menu

Language 

  1. English  (24,837)
  2. Japanese  (3,434)
  3. Portuguese  (199)
  4. German  (193)
  5. French  (141)
  6. Spanish  (132)
  7. Chinese  (61)
  8. Russian  (50)
  9. Czech  (18)
  10. Korean  (17)
  11. Norwegian  (15)
  12. Croatian  (11)
  13. Polish  (7)
  14. Romanian  (7)
  15. Italian  (6)
  16. Serbian  (4)
  17. Catalan  (4)
  18. Ukrainian  (4)
  19. Arabic  (3)
  20. Swedish  (3)
  21. More options open sub menu

Searching Remote Databases, Please Wait